Solid Biosciences Inc.
SLDB
$7.26
$0.212.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.88% | -39.88% | -57.47% | -61.63% | -109.47% |
| Total Depreciation and Amortization | -4.30% | -7.16% | -68.74% | 24.46% | 129.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.78% | -17.68% | 158.80% | 219.41% | 470.68% |
| Change in Net Operating Assets | -722.31% | 152.93% | -443.57% | 162.82% | 184.79% |
| Cash from Operations | -80.65% | -41.18% | -74.28% | -26.43% | -42.37% |
| Capital Expenditure | -176.96% | -466.67% | -31.82% | 15.44% | -126.67% |
| Sale of Property, Plant, and Equipment | 1,600.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.51% | -311.85% | -561.66% | 28.70% | -14.59% |
| Cash from Investing | 21.90% | -312.06% | -532.38% | 28.65% | -14.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -58.59% | -102.50% | 36.89% | -- | -- |
| Issuance of Common Stock | -24.36% | -57.97% | -96.33% | 69.44% | 1,299.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -480.77% | 99.59% | -- |
| Cash from Financing | -25.89% | -63.88% | -132.02% | 76.92% | 1,274.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.81% | -146.73% | -231.49% | 199.40% | -36.50% |